[
  {
    "ts": null,
    "headline": "Despite Setbacks, Moderna Sees Opportunity In Avian Flu, Merck Partnership",
    "summary": "Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.",
    "url": "https://finnhub.io/api/news?id=7efcb5cdd31954e47a93c3033d8407955ee89c3ba35080037da213732014f506",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737294084,
      "headline": "Despite Setbacks, Moderna Sees Opportunity In Avian Flu, Merck Partnership",
      "id": 132425771,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1928832415/image_1928832415.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.",
      "url": "https://finnhub.io/api/news?id=7efcb5cdd31954e47a93c3033d8407955ee89c3ba35080037da213732014f506"
    }
  }
]